corporate welfare from NIH

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

"The US government's strong support has been vital to NexBio's research
and development programs on influenza," says Fang Fang, M.D., Ph.D.,
NexBio's Chief Scientific/Medical Officer. "The mounting threat of an
imminent influenza pandemic, the unreliable vaccine supplies for recent
influenza epidemics, and increasing viral resistance to the limited
selection of antiviral drugs have all added urgency to our cause.
NexBio will continue to work closely with the NIH, CDC, and the FDA to
expedite Fludase® development. We are also actively seeking corporate
partnerships from companies that have extensive experience in late
stage drug development and commercialization," added Dr. Fang.

Influenza is a highly infectious respiratory disease that has plagued
the human race since ancient times. It is characterized by recurrent
annual epidemics and periodic major worldwide pandemics. Every year,
influenza remains the most common cause of medically attended acute
respiratory illness. An influenza pandemic with an H5N1 strain is
considered imminent, and is one of the biggest challenges facing public
health systems worldwide. The shortage of influenza vaccine in recent
years, along with the unavailability of a vaccine for the H5N1
influenza virus, and the emergence of strains resistant to current
antiviral compounds, have caused increasingly serious concerns
regarding this imminent influenza pandemic. While pursuing a fast-track
approval process, NexBio also plans to pursue the possibility of the
emergency use of Fludase® and stockpiling in preparation for the
influenza pandemic.

ABOUT NEXBIO

NexBio, Inc. is a privately held development-stage biopharmaceutical
company located in San Diego. NexBio's mission is to develop novel,
broad-spectrum prophylaxis and therapeutics for the prevention and
treatment of life-threatening human respiratory infectious diseases in
order to save lives and to improve the quality of life.

**********

taxpayers footing bill for corporation, is this really needed?

TC

"Crisis" entered the medical lexicon to describe that critical point in a
disease when the patient either recovers or succumbs. In this sense,
"crisis" aptly describes the state of funding for Canadian research in the
health sciences, and the outcome of this crisis is uncertain. Canada lags
far behind the other major industrialized G7 nations in its funding for
medical research, as summarized below. (A detailed statement can also be
found in the recent report A Crisis in Health Research,1 published by the
Coalition for Biomedical and Health Research (CBHR) and available on the
CBHR Web site at www.cbhr.ca).

http://epe.lac-bac.gc.ca/100/201/300/cdn_medical_association/cim/vol-21/issue-3/0159.htm

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

"The US government's strong support has been vital to NexBio's research
and development programs on influenza," says Fang Fang, M.D., Ph.D.,
NexBio's Chief Scientific/Medical Officer. "The mounting threat of an
imminent influenza pandemic, the unreliable vaccine supplies for recent
influenza epidemics, and increasing viral resistance to the limited
selection of antiviral drugs have all added urgency to our cause.
NexBio will continue to work closely with the NIH, CDC, and the FDA to
expedite Fludase® development. We are also actively seeking corporate
partnerships from companies that have extensive experience in late
stage drug development and commercialization," added Dr. Fang.

Influenza is a highly infectious respiratory disease that has plagued
the human race since ancient times. It is characterized by recurrent
annual epidemics and periodic major worldwide pandemics. Every year,
influenza remains the most common cause of medically attended acute
respiratory illness. An influenza pandemic with an H5N1 strain is
considered imminent, and is one of the biggest challenges facing public
health systems worldwide. The shortage of influenza vaccine in recent
years, along with the unavailability of a vaccine for the H5N1
influenza virus, and the emergence of strains resistant to current
antiviral compounds, have caused increasingly serious concerns
regarding this imminent influenza pandemic. While pursuing a fast-track
approval process, NexBio also plans to pursue the possibility of the
emergency use of Fludase® and stockpiling in preparation for the
influenza pandemic.

ABOUT NEXBIO

NexBio, Inc. is a privately held development-stage biopharmaceutical
company located in San Diego. NexBio's mission is to develop novel,
broad-spectrum prophylaxis and therapeutics for the prevention and
treatment of life-threatening human respiratory infectious diseases in
order to save lives and to improve the quality of life.

**********

taxpayers footing bill for corporation, is this really needed?

TC

"Crisis" entered the medical lexicon to describe that critical point in a
disease when the patient either recovers or succumbs. In this sense,
"crisis" aptly describes the state of funding for Canadian research in the
health sciences, and the outcome of this crisis is uncertain. Canada lags
far behind the other major industrialized G7 nations in its funding for
medical research, as summarized below. (A detailed statement can also be
found in the recent report A Crisis in Health Research,1 published by the
Coalition for Biomedical and Health Research (CBHR) and available on the
CBHR Web site at www.cbhr.ca).

http://epe.lac-bac.gc.ca/100/201/300/cdn_medical_association/cim/vol-21/issue-3/0159.htm

Just because European countries and the US think it is right to spend
billions to do research on behalf of the food and pharceutical
industries, to their sole benefit, does not mean it is useful or
needed. In Canada, we don't subscribe to the idea of providing
corporate welfare to develop medically questionable and most likely
dangerous drug treatments. We are more interested in actually providing
real health care to our people. The research we do is much more
relevant and has led to many more significant and truly scientific
findings than all of the billions spent by the US to bolster their food
and pharma industry with fake "marketing" science. Canadian science, so
far, has been much more focussed and productive than the american
"marketing" science, and will continue to be, in spite of the smaller
amount spent. Quality in science will always trump quantity, especially
the quantity of garbage science the US is producing.

Everyone in Canada has access to health care. And our average life span
is longer than in the US, as are most developed countries.

Why are these billions that are being spent on research in the US not
translating into real health benefits in the US? That is the failure of
the US system. They spend way more per capita for health care and
health related research than anyone else in the entire world, and they
not only see no results, but they see massive negative results in
health status. They are fatter and sicker the the entire rest of the
world. They lead the world in health and research spending and the lead
the world in obesity and sickness.

And that [censored] is happening because the billions of tax dollars being
spent on "research" are being spent on biased garbage "marketing"
science instead of real life-saving health science.

TC

"TC" <[email hidden]> wrote in message
news:[email hidden]...

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

"The US government's strong support has been vital to NexBio's research
and development programs on influenza," says Fang Fang, M.D., Ph.D.,
NexBio's Chief Scientific/Medical Officer. "The mounting threat of an
imminent influenza pandemic, the unreliable vaccine supplies for recent
influenza epidemics, and increasing viral resistance to the limited
selection of antiviral drugs have all added urgency to our cause.
NexBio will continue to work closely with the NIH, CDC, and the FDA to
expedite Fludase® development. We are also actively seeking corporate
partnerships from companies that have extensive experience in late
stage drug development and commercialization," added Dr. Fang.

Influenza is a highly infectious respiratory disease that has plagued
the human race since ancient times. It is characterized by recurrent
annual epidemics and periodic major worldwide pandemics. Every year,
influenza remains the most common cause of medically attended acute
respiratory illness. An influenza pandemic with an H5N1 strain is
considered imminent, and is one of the biggest challenges facing public
health systems worldwide. The shortage of influenza vaccine in recent
years, along with the unavailability of a vaccine for the H5N1
influenza virus, and the emergence of strains resistant to current
antiviral compounds, have caused increasingly serious concerns
regarding this imminent influenza pandemic. While pursuing a fast-track
approval process, NexBio also plans to pursue the possibility of the
emergency use of Fludase® and stockpiling in preparation for the
influenza pandemic.

ABOUT NEXBIO

NexBio, Inc. is a privately held development-stage biopharmaceutical
company located in San Diego. NexBio's mission is to develop novel,
broad-spectrum prophylaxis and therapeutics for the prevention and
treatment of life-threatening human respiratory infectious diseases in
order to save lives and to improve the quality of life.

**********

taxpayers footing bill for corporation, is this really needed?

TC

"Crisis" entered the medical lexicon to describe that critical point in a
disease when the patient either recovers or succumbs. In this sense,
"crisis" aptly describes the state of funding for Canadian research in the
health sciences, and the outcome of this crisis is uncertain. Canada lags
far behind the other major industrialized G7 nations in its funding for
medical research, as summarized below. (A detailed statement can also be
found in the recent report A Crisis in Health Research,1 published by the
Coalition for Biomedical and Health Research (CBHR) and available on the
CBHR Web site at www.cbhr.ca).

http://epe.lac-bac.gc.ca/100/201/300/cdn_medical_association/cim/vol-21/issue-3/0159.htm

Just because European countries and the US think it is right to spend
billions to do research on behalf of the food and pharceutical
industries, to their sole benefit, does not mean it is useful or
needed. In Canada, we don't subscribe to the idea of providing
corporate welfare to develop medically questionable and most likely
dangerous drug treatments. We are more interested in actually providing
real health care to our people. The research we do is much more
relevant and has led to many more significant and truly scientific
findings than all of the billions spent by the US to bolster their food
and pharma industry with fake "marketing" science. Canadian science, so
far, has been much more focussed and productive than the american
"marketing" science, and will continue to be, in spite of the smaller
amount spent. Quality in science will always trump quantity, especially
the quantity of garbage science the US is producing.

Everyone in Canada has access to health care. And our average life span
is longer than in the US, as are most developed countries.

You are a Canadian propagandist for the Canadian government.
You appoligize for every single flaw and [censored] done by the government.
You are simply a troll.

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

"The US government's strong support has been vital to NexBio's research
and development programs on influenza," says Fang Fang, M.D., Ph.D.,
NexBio's Chief Scientific/Medical Officer. "The mounting threat of an
imminent influenza pandemic, the unreliable vaccine supplies for recent
influenza epidemics, and increasing viral resistance to the limited
selection of antiviral drugs have all added urgency to our cause.
NexBio will continue to work closely with the NIH, CDC, and the FDA to
expedite Fludase® development. We are also actively seeking corporate
partnerships from companies that have extensive experience in late
stage drug development and commercialization," added Dr. Fang.

Influenza is a highly infectious respiratory disease that has plagued
the human race since ancient times. It is characterized by recurrent
annual epidemics and periodic major worldwide pandemics. Every year,
influenza remains the most common cause of medically attended acute
respiratory illness. An influenza pandemic with an H5N1 strain is
considered imminent, and is one of the biggest challenges facing public
health systems worldwide. The shortage of influenza vaccine in recent
years, along with the unavailability of a vaccine for the H5N1
influenza virus, and the emergence of strains resistant to current
antiviral compounds, have caused increasingly serious concerns
regarding this imminent influenza pandemic. While pursuing a fast-track
approval process, NexBio also plans to pursue the possibility of the
emergency use of Fludase® and stockpiling in preparation for the
influenza pandemic.

ABOUT NEXBIO

NexBio, Inc. is a privately held development-stage biopharmaceutical
company located in San Diego. NexBio's mission is to develop novel,
broad-spectrum prophylaxis and therapeutics for the prevention and
treatment of life-threatening human respiratory infectious diseases in
order to save lives and to improve the quality of life.

**********

taxpayers footing bill for corporation, is this really needed?

TC

"Crisis" entered the medical lexicon to describe that critical point ina
disease when the patient either recovers or succumbs. In this sense,
"crisis" aptly describes the state of funding for Canadian research in the
health sciences, and the outcome of this crisis is uncertain. Canada lags
far behind the other major industrialized G7 nations in its funding for
medical research, as summarized below. (A detailed statement can also be
found in the recent report A Crisis in Health Research,1 published by the
Coalition for Biomedical and Health Research (CBHR) and available on the
CBHR Web site at www.cbhr.ca).

http://epe.lac-bac.gc.ca/100/201/300/cdn_medical_association/cim/vol-21/issue-3/0159.htm

Just because European countries and the US think it is right to spend
billions to do research on behalf of the food and pharceutical
industries, to their sole benefit, does not mean it is useful or
needed. In Canada, we don't subscribe to the idea of providing
corporate welfare to develop medically questionable and most likely
dangerous drug treatments. We are more interested in actually providing
real health care to our people. The research we do is much more
relevant and has led to many more significant and truly scientific
findings than all of the billions spent by the US to bolster their food
and pharma industry with fake "marketing" science. Canadian science, so
far, has been much more focussed and productive than the american
"marketing" science, and will continue to be, in spite of the smaller
amount spent. Quality in science will always trump quantity, especially
the quantity of garbage science the US is producing.

Everyone in Canada has access to health care. And our average life span
is longer than in the US, as are most developed countries.

You are a Canadian propagandist for the Canadian government.
You appoligize for every single flaw and [censored] done by the government.
You are simply a troll.

Look, moron....

The topic is corruption deep within the bowels of the *US* NIH. If you
want to criricize the Canadian system, you are free to do so. Please
feel free to start your own threads on the topic of Canadian corruption
in the health field. If I feel compelled I will respond.

Do you see how absurd your logic is? I post an article that clearly
spells out the details of abject corruption in the US health system,
you respond by pointing out some malfeasance in the Canadian system.
Well... so what? So your massive american funded systemic corporate
corruption reaches as far as 50 miles north of the US-Canada border. So
what? So Canadian officials and elected officials get pressured to
support the conservative Bush agenda and drug policy. So what?

I don't care if it is in the US or Canada. It does not matter. The
corruption is there. What are you going to do about it?

Are you defending the corruption?

TC

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

"The US government's strong support has been vital to NexBio's research
and development programs on influenza," says Fang Fang, M.D., Ph.D.,
NexBio's Chief Scientific/Medical Officer. "The mounting threat of an
imminent influenza pandemic, the unreliable vaccine supplies for recent
influenza epidemics, and increasing viral resistance to the limited
selection of antiviral drugs have all added urgency to our cause.
NexBio will continue to work closely with the NIH, CDC, and the FDA to
expedite Fludase® development. We are also actively seeking corporate
partnerships from companies that have extensive experience in late
stage drug development and commercialization," added Dr. Fang.

Influenza is a highly infectious respiratory disease that has plagued
the human race since ancient times. It is characterized by recurrent
annual epidemics and periodic major worldwide pandemics. Every year,
influenza remains the most common cause of medically attended acute
respiratory illness. An influenza pandemic with an H5N1 strain is
considered imminent, and is one of the biggest challenges facing public
health systems worldwide. The shortage of influenza vaccine in recent
years, along with the unavailability of a vaccine for the H5N1
influenza virus, and the emergence of strains resistant to current
antiviral compounds, have caused increasingly serious concerns
regarding this imminent influenza pandemic. While pursuing a fast-track
approval process, NexBio also plans to pursue the possibility of the
emergency use of Fludase® and stockpiling in preparation for the
influenza pandemic.

ABOUT NEXBIO

NexBio, Inc. is a privately held development-stage biopharmaceutical
company located in San Diego. NexBio's mission is to develop novel,
broad-spectrum prophylaxis and therapeutics for the prevention and
treatment of life-threatening human respiratory infectious diseases in
order to save lives and to improve the quality of life.

**********

taxpayers footing bill for corporation, is this really needed?

TC

"Crisis" entered the medical lexicon to describe that critical point ina
disease when the patient either recovers or succumbs. In this sense,
"crisis" aptly describes the state of funding for Canadian research in the
health sciences, and the outcome of this crisis is uncertain. Canada lags
far behind the other major industrialized G7 nations in its funding for
medical research, as summarized below. (A detailed statement can also be
found in the recent report A Crisis in Health Research,1 published by the
Coalition for Biomedical and Health Research (CBHR) and available on the
CBHR Web site at www.cbhr.ca).

http://epe.lac-bac.gc.ca/100/201/300/cdn_medical_association/cim/vol-21/issue-3/0159.htm

Just because European countries and the US think it is right to spend
billions to do research on behalf of the food and pharceutical
industries, to their sole benefit, does not mean it is useful or
needed. In Canada, we don't subscribe to the idea of providing
corporate welfare to develop medically questionable and most likely
dangerous drug treatments. We are more interested in actually providing
real health care to our people. The research we do is much more
relevant and has led to many more significant and truly scientific
findings than all of the billions spent by the US to bolster their food
and pharma industry with fake "marketing" science. Canadian science, so
far, has been much more focussed and productive than the american
"marketing" science, and will continue to be, in spite of the smaller
amount spent. Quality in science will always trump quantity, especially
the quantity of garbage science the US is producing.

Everyone in Canada has access to health care. And our average life span
is longer than in the US, as are most developed countries.

You are a Canadian propagandist for the Canadian government.
You appoligize for every single flaw and [censored] done by the government.
You are simply a troll.

Look, moron....

The topic is corruption deep within the bowels of the *US* NIH. If you
want to criricize the Canadian system, you are free to do so. Please
feel free to start your own threads on the topic of Canadian corruption
in the health field. If I feel compelled I will respond.

Do you see how absurd your logic is? I post an article that clearly
spells out the details of abject corruption in the US health system,
you respond by pointing out some malfeasance in the Canadian system.
Well... so what? So your massive american funded systemic corporate
corruption reaches as far as 50 miles north of the US-Canada border. So
what? So Canadian officials and elected officials get pressured to
support the conservative Bush agenda and drug policy. So what?

I don't care if it is in the US or Canada. It does not matter. The
corruption is there. What are you going to do about it?

Are you defending the corruption?

TC

"TC" <[email hidden]> wrote in message > >
Look, moron....

The topic is corruption deep within the bowels of the *US* NIH. If you
want to criricize the Canadian system, you are free to do so. Please
feel free to start your own threads on the topic of Canadian corruption
in the health field. If I feel compelled I will respond.

Do you see how absurd your logic is? I post an article that clearly
spells out the details of abject corruption in the US health system,
you respond by pointing out some malfeasance in the Canadian system.
Well... so what?

SO WHAT. WHAT ARE CANADIANS going to do about it?
You as a Canadian looked at press reports about US healthcare.
SO WHAT. What are you going to do about it?
You post it here. SO WHAT?
As a Canadian, what do you want Americans to do about it?
SO what if they do or don't do anything about it?

So your massive american funded systemic corporate
corruption reaches as far as 50 miles north of the US-Canada border. So
what? So Canadian officials and elected officials get pressured to
support the conservative Bush agenda and drug policy. So what?

Now the truth comes out. So post in Canada about the Canadian health system
corruption so crippled that it relies totally on the FDA and NIH. Change
your own stupid system before as an idiot Canadian trying to change the
American system.

I don't care if it is in the US or Canada. It does not matter. The
corruption is there. What are you going to do about it?

Are you defending the corruption?

TC

You damn well do. Every bad thing up in Canada you have excuses for because
you support the government there.
The same government you say that follows the FDA.
Fix your own mess.

Robert said:

"TC" <[email hidden]> wrote in message > >
Look, moron....

The topic is corruption deep within the bowels of the *US* NIH. If you
want to criricize the Canadian system, you are free to do so. Please
feel free to start your own threads on the topic of Canadian corruption
in the health field. If I feel compelled I will respond.

Do you see how absurd your logic is? I post an article that clearly
spells out the details of abject corruption in the US health system,
you respond by pointing out some malfeasance in the Canadian system.
Well... so what?

SO WHAT. WHAT ARE CANADIANS going to do about it?

We are doing it.

Quoted message said:

You as a Canadian looked at press reports about US healthcare.

Yep, so what?

Quoted message said:

SO WHAT. What are you going to do about it?
You post it here. SO WHAT?
As a Canadian, what do you want Americans to do about it?

Just to be aware of it. We are aware of our problems. You guys, for the
most part, never see it reported in the main press.

Quoted message said:

SO what if they do or don't do anything about it?

Why are you getting your bun in a knot?

Quoted message said:

So your massive american funded systemic corporate
corruption reaches as far as 50 miles north of the US-Canada border. So
what? So Canadian officials and elected officials get pressured to
support the conservative Bush agenda and drug policy. So what?

Now the truth comes out. So post in Canada about the Canadian health system
corruption so crippled that it relies totally on the FDA and NIH. Change
your own stupid system before as an idiot Canadian trying to change the
American system.

We don't rely on the FDA and NIH. We know it is all corrupt [censored]. We
have out own processes up here and it works on a lot less than the
billions you guys throw at pharma.

Let's see, the US spends billions of taxpayers money to help pharma rip
off their own citizens with expensive, dangerous and pretty much
useless drugs, Canada doesn't, and Canada is the stupid one. All
Canadians have health care and forty percent of US citizens have
virtually none and Canada is the stupid system? Canada allows medicare
to negotiate drug prices, the US makes it illegal for their medicare to
negotiate drug prices and Canada is the stupid one?

Quoted message said:

I don't care if it is in the US or Canada. It does not matter. The
corruption is there. What are you going to do about it?

Are you defending the corruption?

TC

You damn well do. Every bad thing up in Canada you have excuses for because
you support the government there.

[censored]. I've yet to make an excuse for any corruption in Canada. It
just does not exist to the same or even vaguely similar extent as it
does in the NIH and the FDA. And you haven't proven that it does.

Quoted message said:

The same government you say that follows the FDA.

It doesn't follow the FDA. It takes the FDA's information and considers
it, just as it does many other countries FDA equivalents around the
world, notably in Europe.

Quoted message said:

Fix your own mess.

Our mess is publicly acknowledged and under control, is yours?

TC

Robert said:

"TC" <[email hidden]> wrote in message > >
Look, moron....

The topic is corruption deep within the bowels of the *US* NIH. If you
want to criricize the Canadian system, you are free to do so. Please
feel free to start your own threads on the topic of Canadian corruption
in the health field. If I feel compelled I will respond.

Do you see how absurd your logic is? I post an article that clearly
spells out the details of abject corruption in the US health system,
you respond by pointing out some malfeasance in the Canadian system.
Well... so what?

SO WHAT. WHAT ARE CANADIANS going to do about it?

We are doing it.

Quoted message said:

You as a Canadian looked at press reports about US healthcare.

Yep, so what?

Quoted message said:

SO WHAT. What are you going to do about it?
You post it here. SO WHAT?
As a Canadian, what do you want Americans to do about it?

Just to be aware of it. We are aware of our problems. You guys, for the
most part, never see it reported in the main press.

Quoted message said:

SO what if they do or don't do anything about it?

Why are you getting your bun in a knot?

Quoted message said:

So your massive american funded systemic corporate
corruption reaches as far as 50 miles north of the US-Canada border. So
what? So Canadian officials and elected officials get pressured to
support the conservative Bush agenda and drug policy. So what?

Now the truth comes out. So post in Canada about the Canadian health system
corruption so crippled that it relies totally on the FDA and NIH. Change
your own stupid system before as an idiot Canadian trying to change the
American system.

We don't rely on the FDA and NIH. We know it is all corrupt [censored]. We
have out own processes up here and it works on a lot less than the
billions you guys throw at pharma.

Let's see, the US spends billions of taxpayers money to help pharma rip
off their own citizens with expensive, dangerous and pretty much
useless drugs, Canada doesn't, and Canada is the stupid one. All
Canadians have health care and forty percent of US citizens have
virtually none and Canada is the stupid system? Canada allows medicare
to negotiate drug prices, the US makes it illegal for their medicare to
negotiate drug prices and Canada is the stupid one?

Quoted message said:

I don't care if it is in the US or Canada. It does not matter. The
corruption is there. What are you going to do about it?

Are you defending the corruption?

TC

You damn well do. Every bad thing up in Canada you have excuses for because
you support the government there.

[censored]. I've yet to make an excuse for any corruption in Canada. It
just does not exist to the same or even vaguely similar extent as it
does in the NIH and the FDA. And you haven't proven that it does.

Quoted message said:

The same government you say that follows the FDA.

It doesn't follow the FDA. It takes the FDA's information and considers
it, just as it does many other countries FDA equivalents around the
world, notably in Europe.

Quoted message said:

Fix your own mess.

Our mess is publicly acknowledged and under control, is yours?

TC

TC said:

We don't rely on the FDA and NIH. We know it is all corrupt [censored]. We
have out own processes up here and it works on a lot less than the
billions you guys throw at pharma.

COMMENT:
"Works on a lot less"?? LOL! Canadian biomed research doesn't do much
work at all, so far as I can see. Whereas in theory, since the
incorruptable Canadian system is free of the corrupt FDA and corrupt US
Pharm industries, it should be free to pump out new efficacious and
safe medications with the incorruptable efficiency of....metaphor
search.... Sergeant Preston of the Yukon RCMP. ("On King! On you
huskies..."😉

Did I miss something? I don't see all these marvels coming down from
Canada these days. The only thing I see coming DOWN is Canadian biotech
stock prices.

Quoted message said:

Let's see, the US spends billions of taxpayers money to help pharma rip
off their own citizens with expensive, dangerous and pretty much
useless drugs, Canada doesn't, and Canada is the stupid one.

COMMENT:
Canada uses all those same drugs, so I'm told (though I still can't
discover if you can get Lamasil pills for your ugly toenails in
Canuckistan, and if you can, how much they cost). If these drugs you're
talking about are truely as expensive and dangerous as you say, why do
you import them at all? Isn't there something homeopathic or locally
invented you can use, instead? Flavored moose droppings, or something?

Quoted message said:

All Canadians have health care and forty percent of US citizens have
virtually none and Canada is the stupid system?

COMMENT

No, I have to admit that Canada has been pretty smart about hanging
back and cloning technologies that first prove themselves elsewhere.
That's a good way to save money, all right. Gosh, we're sure stupid for
not doing that here in the US. I don't KNOW why we didn't think of it.
Thanks for pointing that out.

SBH

PS. Now, how are we supposed to get Canada's strategy to work down
here, again?

TC said:

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

COMMENT:

Why isn't this thread entitled "US foreign aid to Canada, from NIH?"
After all, this money is being used to develop a blockbuster anti-flu
drug that Canada is certain to buy and use, no?

What, Canada is going to refuse to have anything to do with Fludase,
because it was funded by US taxpayers and corporate welfare? I don't
think so.

Quoted message said:

Just because European countries and the US think it is right to spend
billions to do research on behalf of the food and pharceutical
industries, to their sole benefit, does not mean it is useful or
needed.

COMMENT:
If you didn't think it was "useful or needed," you'd be refusing to
avail yourselves of the fruits of it, forever. I don't see that
happenning. Canada might wait till the price comes down, but it will
buy eventually.

Quoted message said:

In Canada, we don't subscribe to the idea of providing
corporate welfare to develop medically questionable and most likely
dangerous drug treatments.

COMMENT:
No, you subscribe to the policy of letting the US Taxpayer do it, after
which you buy the surviving drug treatments later, at hand-me-down
prices.

Quoted message said:

We are more interested in actually providing
real health care to our people.

COMMENT:
You are more interested in freeloading and other people's garage-sales.

Quoted message said:

The research we do is much more
relevant and has led to many more significant and truly scientific
findings than all of the billions spent by the US to bolster their food
and pharma industry with fake "marketing" science.

COMMENT:
Examples needed here. Insulin was 75 years ago, and the
commercialization of it, as with penicillin, was not trivial, and was a
significant peice of scientific work in and of itself, if you know that
story.

Quoted message said:

Canadian science, so
far, has been much more focussed and productive than the american
"marketing" science, and will continue to be, in spite of the smaller
amount spent. Quality in science will always trump quantity, especially
the quantity of garbage science the US is producing.

COMMENT:
Are you really trolling here?

SBH

TC said:

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

COMMENT:

Why isn't this thread entitled "US foreign aid to Canada, from NIH?"
After all, this money is being used to develop a blockbuster anti-flu
drug that Canada is certain to buy and use, no?

What, Canada is going to refuse to have anything to do with Fludase,
because it was funded by US taxpayers and corporate welfare? I don't
think so.

Quoted message said:

Just because European countries and the US think it is right to spend
billions to do research on behalf of the food and pharceutical
industries, to their sole benefit, does not mean it is useful or
needed.

COMMENT:
If you didn't think it was "useful or needed," you'd be refusing to
avail yourselves of the fruits of it, forever. I don't see that
happenning. Canada might wait till the price comes down, but it will
buy eventually.

Quoted message said:

In Canada, we don't subscribe to the idea of providing
corporate welfare to develop medically questionable and most likely
dangerous drug treatments.

COMMENT:
No, you subscribe to the policy of letting the US Taxpayer do it, after
which you buy the surviving drug treatments later, at hand-me-down
prices.

Quoted message said:

We are more interested in actually providing
real health care to our people.

COMMENT:
You are more interested in freeloading and other people's garage-sales.

Quoted message said:

The research we do is much more
relevant and has led to many more significant and truly scientific
findings than all of the billions spent by the US to bolster their food
and pharma industry with fake "marketing" science.

COMMENT:
Examples needed here. Insulin was 75 years ago, and the
commercialization of it, as with penicillin, was not trivial, and was a
significant peice of scientific work in and of itself, if you know that
story.

Quoted message said:

Canadian science, so
far, has been much more focussed and productive than the american
"marketing" science, and will continue to be, in spite of the smaller
amount spent. Quality in science will always trump quantity, especially
the quantity of garbage science the US is producing.

COMMENT:
Are you really trolling here?

SBH

Sbharrisatsignix.netcom.com said:

TC said:

Robert said:

"TC" <[email hidden]> wrote in message
news:[email hidden]...
http://biz.yahoo.com/prnews/050808/lam050.html?.v=19

NexBio Receives a $6 Million NIH SBIR Grant for the Clinical
Development of a Novel Influenza Medicine
Monday August 8, 8:30 am ET

SAN DIEGO, Aug. 8 /PRNewswire/ -- NexBio, Inc. announced today that the
National Institute of Allergy and Infectious Diseases (NIAID), a
component of the National Institutes of Health (NIH), has awarded the
company a $6 million Phase II SBIR Grant to further test the company's
lead drug candidate, Fludase® (DAS181)*, for the prevention and
treatment of influenza. NexBio recently completed a pre-IND
(Investigational New Drug Application) meeting with the U.S. Food and
Drug Administration (FDA) and will submit an IND to FDA and initiate
human trials on Fludase® shortly thereafter.
Fludase® represents a First-In-Class approach to fight influenza. The
drug candidate works by preventing all types and strains of influenza
virus from entering the airway epithelial cells, including avian
influenza as well as parainfluenza viruses. It aims at providing
broad-spectrum protection, improved clinical efficacy, reduced
likelihood of drug resistance, and a cost effective medicine for
influenza. Fludase® will not require annual updates as with influenza
vaccines, and therefore, it can be stockpiled for both annual influenza
epidemics and emergency use for future influenza pandemics.

COMMENT:

Why isn't this thread entitled "US foreign aid to Canada, from NIH?"
After all, this money is being used to develop a blockbuster anti-flu
drug that Canada is certain to buy and use, no?

What, Canada is going to refuse to have anything to do with Fludase,
because it was funded by US taxpayers and corporate welfare? I don't
think so.

Quoted message said:

Just because European countries and the US think it is right to spend
billions to do research on behalf of the food and pharceutical
industries, to their sole benefit, does not mean it is useful or
needed.

COMMENT:
If you didn't think it was "useful or needed," you'd be refusing to
avail yourselves of the fruits of it, forever. I don't see that
happenning. Canada might wait till the price comes down, but it will
buy eventually.

Quoted message said:

In Canada, we don't subscribe to the idea of providing
corporate welfare to develop medically questionable and most likely
dangerous drug treatments.

COMMENT:
No, you subscribe to the policy of letting the US Taxpayer do it, after
which you buy the surviving drug treatments later, at hand-me-down
prices.

Quoted message said:

We are more interested in actually providing
real health care to our people.

COMMENT:
You are more interested in freeloading and other people's garage-sales.

Quoted message said:

The research we do is much more
relevant and has led to many more significant and truly scientific
findings than all of the billions spent by the US to bolster their food
and pharma industry with fake "marketing" science.

COMMENT:
Examples needed here. Insulin was 75 years ago, and the
commercialization of it, as with penicillin, was not trivial, and was a
significant peice of scientific work in and of itself, if you know that
story.

Quoted message said:

Canadian science, so
far, has been much more focussed and productive than the american
"marketing" science, and will continue to be, in spite of the smaller
amount spent. Quality in science will always trump quantity, especially
the quantity of garbage science the US is producing.

COMMENT:
Are you really trolling here?

SBH

You know that you've hit a real nerve with these shameless pharma
apologists in this ng when they go nuts about where you are from and
are completely unable to come up with anything to say about the content
original post.

Check and mate.

TC